SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention

The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a high-risk viral agent involved in the recent pandemic stated worldwide by the World Health Organization. The infection is correlated to a severe systemic and respiratory disease in many cases, which is clinically treated with a mu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Microorganisms
Päätekijät: Inchingolo, Alessio Danilo, Inchingolo, Angelo Michele, Bordea, Ioana Roxana, Malcangi, Giuseppina, Xhajanka, Edit, Scarano, Antonio, Lorusso, Felice, Farronato, Marco, Tartaglia, Gianluca Martino, Isacco, Ciro Gargiulo, Marinelli, Grazia, D’Oria, Maria Teresa, Hazballa, Denisa, Santacroce, Luigi, Ballini, Andrea, Contaldo, Maria, Inchingolo, Francesco, Dipalma, Gianna
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2021
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7999785/
https://ncbi.nlm.nih.gov/pubmed/33806624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/microorganisms9030525
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia